Search Results - "Cunningham, Evan B."

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review by Degenhardt, Louisa, Peacock, Amy, Colledge, Samantha, Leung, Janni, Grebely, Jason, Vickerman, Peter, Stone, Jack, Cunningham, Evan B, Trickey, Adam, Dumchev, Kostyantyn, Lynskey, Michael, Griffiths, Paul, Mattick, Richard P, Hickman, Matthew, Larney, Sarah

“…Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease burden and a contributor to blood-borne virus transmission. We did a…”
Get full text

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review by Larney, Sarah, Peacock, Amy, Leung, Janni, Colledge, Samantha, Hickman, Matthew, Vickerman, Peter, Grebely, Jason, Dumchev, Kostyantyn V, Griffiths, Paul, Hines, Lindsey, Cunningham, Evan B, Mattick, Richard P, Lynskey, Michael, Marsden, John, Strang, John, Degenhardt, Louisa

“…People who inject drugs (PWID) are a key population affected by the global HIV and hepatitis C virus (HCV) epidemics. HIV and HCV prevention interventions for…”
Get full text

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis by Hajarizadeh, Behzad, Cunningham, Evan B., Valerio, Heather, Martinello, Marianne, Law, Matthew, Janjua, Naveed Z., Midgard, Håvard, Dalgard, Olav, Dillon, John, Hickman, Matthew, Bruneau, Julie, Dore, Gregory J., Grebely, Jason

“…HCV reinfection following successful treatment can compromise treatment outcomes. This systematic review assessed the rate of HCV reinfection following…”
Get full text

Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis by Hajarizadeh, Behzad, Cunningham, Evan B, Reid, Hannah, Law, Matthew, Dore, Gregory J, Grebely, Jason

“…There are concerns around poorer response to direct-acting antiviral (DAA) therapy for hepatitis C virus infection among people who use drugs. This systematic…”
Get more information

Mixed HCV infection and reinfection in people who inject drugs—impact on therapy by Cunningham, Evan B., Applegate, Tanya L., Lloyd, Andrew R., Dore, Gregory J., Grebely, Jason

“…Key Points As a result of ongoing high-risk behaviours, people who inject drugs (PWID) might commonly harbour mixed HCV infections and are at risk of…”
Get full text

Treatment adherence and support for people who inject drugs taking direct‐acting antiviral therapy for hepatitis C infection by Read, Phillip, Gilliver, Rosie, Kearley, John, Lothian, Rebecca, Cunningham, Evan B., Chronister, Karen J., Dore, Gregory J.

“…A community‐based public health facility in Sydney, Australia, the Kirketon Road Centre (KRC), provides health care to people who inject drugs (PWID), homeless…”
Get full text

Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre‐exposure prophylaxis in Taiwan: a modelling study by Wu, Huei‐Jiuan, Shih, Sophy TingFang, Applegate, Tanya L., Kwon, Jisoo A., Cunningham, Evan B., Grebely, Jason, Gray, Richard T.

“…Introduction Simplified hepatitis C virus (HCV) diagnostic strategies have the potential to improve HCV diagnoses and treatment. We aimed to investigate the…”
Get full text

Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study by Conway, Anna, Read, Phillip, Gilliver, Rosie, McNaughton, Tony, Valerio, Heather, Cunningham, Evan B, Henderson, Charles, Hadlow, Brett, Molloy, Katrina, Doab, Anna, Tillakeratne, Shane, Pepolim, Lucy, Harrod, Mary Ellen, Dore, Gregory J, Grebely, Jason

“…New technologies and therapies allow the possibility of a single-visit test and treat model for hepatitis C virus (HCV), addressing some of the barriers to…”
Get full text

Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis by Hines, Lindsey A, Trickey, Adam, Leung, Janni, Larney, Sarah, Peacock, Amy, Degenhardt, Louisa, Colledge, Samantha, Hickman, Matthew, Grebely, Jason, Cunningham, Evan B, Stone, Jack, Dumchev, Kostyantyn, Griffiths, Paul, Vickerman, Peter, Mattick, Richard P, Lynskey, Michael

“…Globally, an estimated 15·6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID),…”
Get full text

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review by Bajis, Sahar, Dore, Gregory J., Hajarizadeh, Behzad, Cunningham, Evan B., Maher, Lisa, Grebely, Jason

“…The burden of hepatitis C virus (HCV) infection is escalating among people who inject drugs (PWID), yet testing and treatment remains suboptimal. The aim of…”
Get full text

Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO‐C): An open‐label, single‐arm, phase 4, multicentre trial by Grebely, Jason, Read, Phillip, Cunningham, Evan B., Weltman, Martin, Matthews, Gail V., Dunlop, Adrian, Montebello, Mark, Martinello, Marianne, Gilliver, Rosie, Marks, Philippa, Applegate, Tanya L., Dore, Gregory J.

“…Background and Aims Direct‐acting antiviral therapy for hepatitis C virus (HCV) is effective, but few prospective studies among people with ongoing injecting…”
Get full text

Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs by Grebely, Jason, Larney, Sarah, Peacock, Amy, Colledge, Samantha, Leung, Janni, Hickman, Matthew, Vickerman, Peter, Blach, Sarah, Cunningham, Evan B., Dumchev, Kostyantyn, Lynskey, Michael, Stone, Jack, Trickey, Adam, Razavi, Homie, Mattick, Richard P., Farrell, Michael, Dore, Gregory J., Degenhardt, Louisa

“…Background and Aims People who have recently injected drugs are a priority population in efforts to achieve hepatitis C virus (HCV) elimination. This study…”
Get full text

A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study by Sheehan, Yumi, Cunningham, Evan B., Cochrane, Amanda, Byrne, Marianne, Brown, Tracey, McGrath, Colette, Lafferty, Lise, Tedla, Nicodemus, Dore, Gregory J., Lloyd, Andrew R., Grebely, Jason

“…Prisons are key venues for scaling-up hepatitis C virus (HCV) testing and treatment. Complex clinical pathways and frequent movements of people in prison…”
Get full text

Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review by Degenhardt, Louisa, Webb, Paige, Colledge-Frisby, Samantha, Ireland, Jeremy, Wheeler, Alice, Ottaviano, Sophie, Willing, Alex, Kairouz, Abe, Cunningham, Evan B, Hajarizadeh, Behzad, Leung, Janni, Tran, Lucy T, Price, Olivia, Peacock, Amy, Vickerman, Peter, Farrell, Michael, Dore, Gregory J, Hickman, Matthew, Grebely, Jason

“…People who inject drugs are exposed to various and changing risk environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed…”
Get full text

Hepatitis C treatment outcome among people in prison: The SToP-C study by Ryan, Hannah, Dore, Gregory J, Grebely, Jason, Byrne, Marianne, Cunningham, Evan B, Martinello, Marianne, Lloyd, Andrew R, Hajarizadeh, Behzad

“…Hepatitis C virus (HCV) burden is higher among people in prison given high prevalence of injecting drug use. This study evaluated direct-acting antiviral (DAA)…”
Get full text

Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review by Colledge-Frisby, Samantha, Ottaviano, Sophie, Webb, Paige, Grebely, Jason, Wheeler, Alice, Cunningham, Evan B, Hajarizadeh, Behzad, Leung, Janni, Peacock, Amy, Vickerman, Peter, Farrell, Michael, Dore, Gregory J, Hickman, Matthew, Degenhardt, Louisa

“…Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of…”
Get full text

A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs—Do Gender-Based Differences Vary by Country-Level Indicators? by Leung, Janni, Peacock, Amy, Colledge, Samantha, Grebely, Jason, Cunningham, Evan B, Hickman, Matthew, Vickerman, Peter, Stone, Jack, Trickey, Adam, Dumchev, Kostyantyn, Lynskey, Michael, Hines, Lindsey, Griffiths, Paul, Mattick, Richard P, Degenhardt, Louisa, Larney, Sarah

“…Abstract Background Women-specific factors exist that increases vulnerability to drug-related harms from injection drug use, including blood-borne viruses…”
Get full text

Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis by Cunningham, Evan B, Wheeler, Alice, Hajarizadeh, Behzad, French, Clare E, Roche, Rachel, Marshall, Alison D, Fontaine, Guillaume, Conway, Anna, Valencia, Braulio M, Bajis, Sahar, Presseau, Justin, Ward, John W, Degenhardt, Louisa, Dore, Gregory J, Hickman, Matthew, Vickerman, Peter, Grebely, Jason

“…Despite the goal set by WHO to eliminate hepatitis C virus (HCV) as a public health threat, uptake of HCV testing and treatment remains low. To achieve this…”
Get more information

Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs by Cunningham, Evan B, Hajarizadeh, Behzad, Amin, Janaki, Hellard, Margaret, Bruneau, Julie, Feld, Jordan J, Cooper, Curtis, Powis, Jeff, Litwin, Alain H, Marks, Philippa, Dalgard, Olav, Conway, Brian, Moriggia, Alberto, Stedman, Catherine, Read, Phillip, Bruggmann, Philip, Lacombe, Karine, Dunlop, Adrian, Applegate, Tanya L, Matthews, Gail V, Fraser, Chris, Dore, Gregory J, Grebely, Jason

“…The aim of this analysis was to calculate the incidence of hepatitis C virus (HCV) reinfection and associated factors among 2 clinical trials of HCV…”
Get full text

Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study by Kwon, Jisoo A., Dore, Gregory J., Grebely, Jason, Hajarizadeh, Behzad, Guy, Rebecca, Cunningham, Evan B., Power, Cherie, Estes, Chris, Razavi, Homie, Gray, Richard T., Dunlop, Adrian, Zekry, Amany, Lloyd, Andrew, Duvnjak, Angella, Treloar, Carla, Tyrrell, Helen, George, Jacob, Iversen, Jenny, Marriott, Kevin, Crooks, Levinia, Maher, Lisa, Douglas, Mark

“…Summary Subsidized direct‐acting antiviral (DAA) treatment recently became available to all adults living with chronic hepatitis C virus (HCV) in Australia…”
Get full text